GE HealthCare Files 8-K

Ticker: GEHC · Form: 8-K · Filed: 2024-11-21T00:00:00.000Z

Sentiment: neutral

Topics: regulation-fd, financial-statements, filing

Related Tickers: GEHC

TL;DR

GE HealthCare filed a standard 8-K, no major news.

AI Summary

GE HealthCare Technologies Inc. filed an 8-K on November 21, 2024, to report information under Regulation FD and to file financial statements and exhibits. The filing does not disclose specific new financial figures or material events beyond routine reporting requirements.

Why It Matters

This 8-K filing indicates routine corporate reporting by GE HealthCare Technologies Inc., without immediate news of significant events or financial changes.

Risk Assessment

Risk Level: low — The filing is a routine 8-K for Regulation FD disclosure and financial statements, not indicating any new risks or material changes.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing for GE HealthCare Technologies Inc.?

The primary purpose is to report information under Regulation FD Disclosure and to file Financial Statements and Exhibits.

On what date was this 8-K report filed?

The report was filed on November 21, 2024.

In which U.S. state is GE HealthCare Technologies Inc. incorporated?

GE HealthCare Technologies Inc. is incorporated in Delaware.

What is the principal executive office address for GE HealthCare Technologies Inc.?

The principal executive office is located at 500 W. Monroe Street, Chicago, IL 60661.

Does this filing indicate any specific new financial results or material events?

No, this filing is a routine 8-K for Regulation FD and financial statements/exhibits, and does not specify new financial results or material events.

From the Filing

0001932393-24-000054.txt : 20241121 0001932393-24-000054.hdr.sgml : 20241121 20241121060520 ACCESSION NUMBER: 0001932393-24-000054 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20241121 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20241121 DATE AS OF CHANGE: 20241121 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GE HealthCare Technologies Inc. CENTRAL INDEX KEY: 0001932393 STANDARD INDUSTRIAL CLASSIFICATION: X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS [3844] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 882515116 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-41528 FILM NUMBER: 241482045 BUSINESS ADDRESS: STREET 1: 500 WEST MONROE STREET CITY: CHICAGO STATE: IL ZIP: 60661 BUSINESS PHONE: 833-735-1139 MAIL ADDRESS: STREET 1: 500 WEST MONROE STREET CITY: CHICAGO STATE: IL ZIP: 60661 FORMER COMPANY: FORMER CONFORMED NAME: GE Healthcare Holding LLC DATE OF NAME CHANGE: 20220603 8-K 1 gehc-20241121.htm 8-K gehc-20241121 0001932393 false 0001932393 2024-11-21 2024-11-21 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 21, 2024 GE HEALTHCARE TECHNOLOGIES INC. (Exact name of registrant as specified in its charter)   Delaware 001-41528 88-2515116 (State or other jurisdiction of incorporation) (Commission  File Number) (IRS Employer Identification No.)       500 W. Monroe Street, Chicago, IL   60661 (Address of principal executive offices)   (Zip Code)         (Registrant’s telephone number, including area code) ( 833 ) 735-1139 ______________________________________________ (Former name or former address, if changed since last report.) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below): ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)  ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common stock, par value $0.01 per share GEHC The Nasdaq Stock Market LLC Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards pursuant to Section 13(a) of the Exchange Act. ☐ Item 7.01 Regulation FD Disclosure. On November 21, 2024, GE HealthCare Technologies Inc. (“we” or “GE HealthCare”) issued a press release in connection with our previously announced 2024 Investor Day. A copy of the press release is furnished as Exhibit 99 to this Current Report on Form 8-K. The information furnished pursuant to Item 7.01, including Exhibit 99, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities under that Section and shall not be dee

View on Read The Filing